Immunome Inc. Insider Buying: Director Jean‑Jacques Biénaime Buys 5,000 Shares Amid Stock Decline—Signal of Confidence in Antibody Platform?
Insider buying at Immunome signals confidence amid volatility—an insider‑led boost that may hint at future upside for cautious investors.
2 minutes to read


